Nbw Capital LLC Repligen Corp Transaction History

Nbw Capital LLC

$510 Million
Q3 2024

A detailed history of Nbw Capital LLC transactions in Repligen Corp stock. As of the latest transaction made, Nbw Capital LLC holds 21,042 shares of RGEN stock, worth $2.62 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

21,042

Previous 36,067 41.66%

Holding current value

$2.62 Million

Previous $4.55 Million 31.13%

% of portfolio

0.61%

Previous 0.91%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$119.79 - $167.35 $1.8 Million - $2.51 Million	-15,025 Reduced 41.66%	21,042 $3.13 Million
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $294,120 - $448,410	2,451 Added 7.29%	36,067 $4.55 Million
Q1 2024 Jun 13, 2024	BUY	$170.78 - $208.42 $98,710 - $120,466	578 Added 1.75%	33,616 $6.18 Million
Q4 2023 Jan 31, 2024	BUY	$114.17 - $185.35 $302,550 - $491,177	2,650 Added 8.72%	33,038 $5.94 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $78,410 - $99,728	565 Added 1.89%	30,388 $4.83 Million
Q2 2023 Aug 15, 2023	BUY	$138.42 - $180.31 $234,206 - $305,084	1,692 Added 6.01%	29,823 $4.22 Million
Q1 2023 May 11, 2023	BUY	$154.26 - $198.1 $1.31 Million - $1.68 Million	8,468 Added 43.07%	28,131 $4.74 Million
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $789,523 - $1.07 Million	-4,861 Reduced 19.82%	19,663 $3.33 Million
Q3 2022 Nov 03, 2022	BUY	$160.42 - $256.21 $681,945 - $1.09 Million	4,251 Added 20.97%	24,524 $4.59 Million
Q2 2022 Aug 01, 2022	SELL	$140.68 - $188.02 $63,868 - $85,361	-454 Reduced 2.19%	20,273 $3.29 Million
Q1 2022 May 04, 2022	SELL	$161.19 - $257.96 $22,727 - $36,372	-141 Reduced 0.68%	20,727 $3.9 Million
Q4 2021 Feb 03, 2022	BUY	$247.59 - $304.47 $236,696 - $291,073	956 Added 4.8%	20,868 $5.53 Million
Q3 2021 Nov 03, 2021	SELL	$194.77 - $324.21 $1.22 Million - $2.03 Million	-6,246 Reduced 23.88%	19,912 $5.75 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $131,700 - $175,434	794 Added 3.13%	26,158 $5.22 Million
Q1 2021 May 05, 2021	BUY	$180.37 - $226.26 $1.08 Million - $1.35 Million	5,970 Added 30.78%	25,364 $4.93 Million
Q4 2020 Feb 09, 2021	SELL	$148.08 - $206.57 $1.44 Million - $2 Million	-9,697 Reduced 33.33%	19,394 $3.72 Million
Q3 2020 Nov 05, 2020	BUY	$122.51 - $158.27 $255,555 - $330,151	2,086 Added 7.72%	29,091 $4.29 Million
Q2 2020 Aug 07, 2020	SELL	$94.33 - $140.48 $1.26 Million - $1.88 Million	-13,389 Reduced 33.15%	27,005 $3.34 Million
Q1 2020 May 11, 2020	SELL	$84.96 - $109.14 $209,511 - $269,139	-2,466 Reduced 5.75%	40,394 $3.9 Million
Q4 2019 Feb 18, 2020	SELL	$73.84 - $93.08 $27,246 - $34,346	-369 Reduced 0.85%	42,860 $3.97 Million
Q3 2019 Nov 04, 2019	BUY	$76.65 - $95.51 $600,169 - $747,843	7,830 Added 22.12%	43,229 $3.32 Million
Q2 2019 Aug 05, 2019	SELL	$54.2 - $85.95 $29,376 - $46,584	-542 Reduced 1.51%	35,399 $3.04 Million
Q1 2019 May 13, 2019	SELL	$49.45 - $62.8 $8,109 - $10,299	-164 Reduced 0.45%	35,941 $2.12 Million
Q4 2018 Feb 11, 2019	BUY	$48.26 - $68.88 $15,346 - $21,903	318 Added 0.89%	36,105 $1.9 Million
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $593,002 - $747,208	-12,671 Reduced 26.15%	35,787 $1.99 Million
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $22,566 - $30,105	640 Added 1.34%	48,458 $2.28 Million
Q1 2018 May 07, 2018	BUY	$30.92 - $37.27 $135,213 - $162,981	4,373 Added 10.07%	47,818 $1.73 Million
Q4 2017 Feb 14, 2018	SELL	$32.53 - $38.92 $12,068 - $14,439	-371 Reduced 0.85%	43,445 $0
Q3 2017 Nov 14, 2017	SELL	$36.98 - $46.06 $3,439 - $4,283	-93 Reduced 0.21%	43,816 $1.68 Million
Q2 2017 Aug 15, 2017	BUY	N/A	43,909	43,909 $1.82 Million

Others Institutions Holding RGEN

# of Institutions

487

Shares Held

54.4M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbw Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nbw Capital LLC with notifications on news.

Account